Background: How well the motor symptoms assessed by the motor section of the Unified Parkinson Disease Rating Scale (UPDRS3) reflect the neuronal loss observed in the substantia nigra is not known.
T HE MOTOR SECTION OF THE
Unified Parkinson Disease Rating Scale (UPDRS3) 1 has, to our knowledge, never been correlated with anatomical data in idiopathic Parkinson disease (IPD) and dementia with Lewy bodies (DLB), although a significant association has been found between the number of key UPDRS parkinsonian signs and a decreasing neuronal density in the substantia nigra of elderly patients without IPD. 2 The kinetics of neuronal loss has been studied previously, 3 and was recently discussed with new data obtained with fluorodopa-positron emission tomography, suggesting a linear 4 or a negative exponential 5 loss of dopaminergic fibers in relation to time. We have correlated the neuronal loss in the substantia nigra with the UPDRS3 score in aged patients affected by Parkinson disease and DLB.
METHODS

STUDY SUBJECTS
The patients, hospitalized in a long-term care facility, were studied prospectively from January 1, 1993 , to December 31, 1999. The clinical inclusion criterion was a parkinsonian syndrome of progressive onset identified by trained neurologists (M.V. and A.-M.B.). Included patients were examined at least once a year. The UPDRS3 was used to assess the motor impairment. 1, 6 The Mini-Mental State Examination 7 was repeated each year. Clinical diagnosis of probable IPD and probable DLB relied on the criteria of Hughes et al 8 and McKeith et al, 9 re- spectively. The year of the first motor symptom was determined by asking the patient or the patient's family. The patients underwent autopsy after consent from their authorized legal representatives. The diagnosis of Lewy body disease (LBD) was made regardless of the clinical information as soon as Lewy bodies were revealed by ␣-synuclein immunohistochemistry. Only patients with LBD underwent analysis in this study. Five age-matched control cases (mean age, 84.4 years) without signs or symptoms of IPD, with normal substantia nigra, and without Lewy bodies after ␣-synuclein immunohistochemisty were selected retrospectively in the Laboratory of Neuropathology Raymond Escourolle, Pitié-Salpêtrière Hospital, Assistance Publique Hô pitaux de Paris, Paris, France.
LABORATORY METHODS
One hemisphere, randomly chosen as the right or the left, was fixed in formaldehyde for at least 2 months. After paraffin embedding, single sections were obtained from the upper surface of the mesencephalon at the level of the superior colliculus and stained with hematoxylin-eosin. Immunohistochemistry was performed with primary antibodies directed against ␣-synuclein (mouse monoclonal antibody; clone LB509; CliniSciences, Montrouge, France) and tau (rabbit polyclonal antibody; batch 122; Dako, Carpenteria, Calif ).
Sections from the hippocampus, entorhinal cortex, and isocortex were immunostained by A␤ (mouse monoclonal; clone 124; Dako) and tau (rabbit polyclonal; batch 122; Dako) antibodies to stage the cases according to the criteria of Braak and Braak. 10 Maps of the pars compacta of the substantia nigra were manually drawn using Mercator software (provided by Explora Nova, La Rochelle, France). 11 All of the profiles bearing a nucleus with a nucleolus were identified as neuronal (so that, actually, the procedure consisted of counting nucleoli).
The polygon that was automatically drawn around each neuronal profile delineated the space that was free of any neighbor neuron (the computer program is available on the Internet at http://www.u106.eu.org/~charles/tel.htm). These polygons, each one containing only 1 neuronal profile, tessellated the substantia nigra. In the density maps of Figure 1 , the small polygons were painted in black to highlight areas of high density where contiguous neurons are close to each other. Large polygons, painted in clear shades, meant low density. 12 An estimate of the neuronal density per unit area was determined by dividing 1 by the mean size of the polygons. 11, 12 To reduce the importance of the border effects on the size of the polygons, an "erosion," 13 defined as taking out all of the profiles touching the peripheral border of the substantia nigra, was performed before measuring the neuronal density. The density per unit volume was estimated by the following formula by Abercrombie 14 
:
Density per Volume = Density per Area/(Section ThicknessϩDiameter of Nucleolus).
The section thickness was measured by a transducer (Heidenhain Corp, Schaumburg, Ill) fixed on the moving stage of the microscope along the z-axis with a step of 0.5 µm. 11 The mean value (6.23 µm; coefficient of error [CE], 3%), in a sample of 6 cases, was used as an estimate of the section thickness for the whole population. There was no "case" factor explaining variability in the measurement (analysis of variance, F=0.7 [P=.60]). We measured 102 nucleoli in 5 IPD cases and 45 in 3 controls, using a micrometric scale (objective, ϫ100; optic aperture, 1.25). The mean diameter was 3.23 µm (CE, 2%) in the patients and 3.84 µm in the controls (CE, 2%). These values were statistically different (unpaired, 2-tailed, t test, −4.6 [PϽ.001]). The neuronal density per cubic millimeter was therefore estimated using different values for the patients (3.23 µm) and controls (3.84 µm).
STATISTICAL ANALYSIS
We used the Pearson correlation coefficient r to compare 2 quantitative values. Differences between patient groups were analyzed using analysis of variance and Fisher protected least significant difference. To illustrate the shape of the relationship between the duration of disease on one hand and UPDRS3 score or neuronal loss in the substantia nigra on the other, a moving average was taken between 5 successive values, and a curve was drawn between these values.
RESULTS
CLINICAL DATA
We examined 103 cases for study inclusion. Of these, 76 had died at the end of the study. The family had allowed the autopsy in 36 cases. Eighteen cases had Lewy bodies at the postmortem examination and were included in the study (Table) . They had been followed up for a mean ± SEM of 24.7 ± 0.3 months. In all the cases, even in those identified as DLB, motor symptoms were given by the patient or the patient's family as the first symptom, sometimes contemporarily with the cognitive deficit (3 cases). The UPDRS3 scores on the left and right sides of the body were not significantly different. The prevalence of tremor was low (5 cases of IPD). Rigidity and akinesia were the main motor symptoms in all cases. All of the patients, except 1, were cognitively impaired. Figure 1 . Density maps of the substantia nigra. Neuronal density map of the substantia nigra (estimated using a tessellation method 11, 12 ) of 5 control cases and 18 cases with Lewy body disease (including idiopathic Parkinson disease and dementia with Lewy bodies). The maps were ranked according to the density of neuronal profiles, from high to low. Shades of gray indicate the neuronal density in neurons per cubic millimeter. Each map is oriented in the same way. the neurons were lost at the first symptom and 50% were lost after 5 years of symptomatic disease (Figure 3) .
NEUROPATHOLOGICAL DATA
Comparison of the progression of the neuronal loss and the value of the UPDRS3 (Figure 4) , using moving averages, showed that both increased dramatically within the first 5 years of symptomatic disease and then tailed off. It was quite remarkable and unexpected that the motor score was close to the decrease in neuronal density (expressed as a percentage of controls); eg, a UPDRS3 score of 57 corresponded to a decrease of 59% in neuronal density after a clinical course of 10 years.
COMMENT
These data suggest that the motor score of the UPDRS, now in the process of being revised, is a good predictor of the neuronal loss. It also shows that the numerical value of the score is remarkably and unexpectedly parallel to the neuronal loss.
The evaluation of neuronal density was performed on a single section with an original mapping method. The neuronal density in a section is the result of 2 counteracting effects: cell loss and atrophy of the anatomical structure. This atrophy, compensating for cell loss, buffers the decrease in neuronal density and tends to mask the loss. The general agreement between the single section count and the disector method, mentioned by Ma et al, 15 indicates that the neuronal density truthfully reflects the total number of neurons because the atrophy of the substantia nigra remains modest. 16 Rinne et al 17 mentioned a negative correlation between bradykinesia, or rigidity, assessed by the Columbia University Rating Scale and neuronal loss in the lateral part of the pars compacta of the substantia nigra. Tremor was positively correlated with neuronal density. The absence of any correlation with tremor in our study may be due to the large number of DLB and IPD cases with dementia in the cohort, with both clinical forms characterized by a low prevalence of tremor. 18 Our figures for the duration of the presymptomatic phase are in good agreement with data published by Fearnley and Lees. 3 The extrapolation of the negative exponential relationship in that report suggested that the presymptomatic phase reached 4.7 years (our value was 5 years). These findings concur in showing that the onset of Parkinson disease antedates the onset of symptoms by years.
Our results are also remarkably consistent with findings obtained with positron emission tomography. The symptoms became apparent when the neuronal loss reached 29% in this study and when the loss of dopaminergic fibers was 31% in the study by Hilker et al. 5 These data are discrepant with the traditional view that 60% to 80% of the neurons have to be lost in the substantia nigra before the first symptoms are noticed. 19 Hilker et al 5 found a preclinical disease period of 5.6 years and an exponential progression of the disease. The slope of the curve in semi-log coordinates is 0.028, implying that the density of dopaminergic endings in the putamen is 10 −0.028 times the density found in the preceding year, 10 −0.028 = 0.93, a value identical to the one we found with our neuronal counts. These convergent results, obtained by neuronal count (this study) and by an assessment of receptor density at the synaptic terminal, 5 suggest that the proportion of lost nerve endings equals the proportion of lost neurons, the arborization of each neuron being probably and on average of similar range in the putamen. It also suggests that progression of the disease is similar in the relatively young patients studied by Hilker et al 5 and in our cohort of elderly individuals. 
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